Luminate, a startup developing wearable devices to improve cancer treatment, has raised $15 million in a Series A funding round to accelerate its innovation and bring cancer care into patients’ homes. Led by Artis Ventures, with participation from Metaplanet, Lachy Groom, 8VC, SciFounders, and Faber, this latest investment will enable Luminate to expand its U.S. presence and move closer to FDA approval…
Melodi Health, a medical device company based in Minneapolis, announced two significant milestones last week. The company successfully closed a $10.75 million oversubscribed Series A funding round and launched the “ARIA” investigational device exemption (IDE) trial, designed to improve outcomes for women undergoing breast reconstruction following mastectomy. The funds raised will support ongoing clinical activities and further product development. Melodi Health, founded…
Cairn Surgical, a medtech company focused on enhancing the precision of breast cancer surgeries, has successfully closed $4.5 million in Series A2 financing led by Morningside Ventures. The newly acquired funds will be directed towards completing the pivotal U.S. trial of Cairn Surgical’s Breast Cancer Locator (BCL™) System, a novel technology designed to significantly enhance the accuracy of breast-conserving surgeries, commonly known…
Daiichi Sankyo and AstraZeneca’s HER2-directed antibody-drug conjugate (ADC) ENHERTU has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for the treatment of unresectable or metastatic hormone receptor-positive HER2 low or HER2 ultralow breast cancer. This latest designation marks the eighth BTD for ENHERTU and highlights the significant potential for the therapy in addressing unmet medical needs…
Canadian-based Noze, a company working on breath-based diagnostics, has secured a $5 million equity investment from the Bill & Melinda Gates Foundation. This investment anchors a new funding round for the breath-based diagnostics startup. The funding follows two previous grants from the foundation, bringing its total contribution to $6.8 million. The funding will support further development of Noze’s disease detection platform for…
Papcup has introduced a non-invasive, at-home device designed to screen for cancer-causing HPV strains using regular menstrual blood. This device, developed with support from the Venture Builder Incubator (VBI) at the University of Edinburgh, aims to provide an alternative to traditional smear tests, which many women find uncomfortable and inconvenient. The device offers a highly accurate, non-invasive method for testing, allowing women…
Digital health company Sidekick Health has announced its acquisition of PINK!, a digital therapeutics company specializing in cancer support and women’s health. This strategic move is set to enhance Sidekick Health’s portfolio and strengthen its position in the DTx market. PINK! Coach, a prescription digital therapeutic (PDT) for breast cancer within Germany’s regulated nationwide DiGA (Digitale Gesundheitsanwendungen) formulary, will now be part…
Digital therapeutics company Mika Health has announced a new collaboration with AstraZeneca and Daiichi Sankyo. The initiative, named “UNITE,” aims to enhance the treatment experience for women undergoing breast cancer therapy in Switzerland through the use of Mika Health’s AI-enabled mobile platform. The UNITE initiative was unveiled at the HLTH Europe conference and signifies a significant step towards integrating digital solutions in…
